Pereira Luciana Xavier, Viana Celso Tarso Rodrigues, Orellano Laura Alejandra Ariza, Almeida Simone Aparecida, Vasconcelos Anilton Cesar, Goes Alfredo de Miranda, Birbrair Alexander, Andrade Silvia Passos, Campos Paula Peixoto
Department of General Pathology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Department of Biochemistry and Immunology of Federal University Minas Gerais, Brazil.
Life Sci. 2017 May 1;176:67-74. doi: 10.1016/j.lfs.2017.03.015. Epub 2017 Mar 21.
Several alternative cellular approaches using biomaterials to host insulin-producing cells derived from stem cells have been developed to overcome the limitations of type 1 diabetes treatment (exogenous insulin injection). However, none seem to fulfill all requirements needed to induce pancreatic cells successful colonization of the scaffolds. Here, we report a polymeric platform adherent to the native mice pancreas filled with human adipose stem cells (hASCs) that was able to induce growth of pancreatic parenchyma.
Synthetic polyether-polyurethane discs were placed adjacent to pancreas of normoglycemic and streptozotocin-induced diabetic mice. At day 4 post implantation, 1×10 hASCs were injected intra-implant in groups of normoglycemic and diabetic mice. Immunohistochemistry analysis of the implants was performed to identify insulin positive cells in the newly formed tissue. In addition, metabolic, inflammatory and angiogenic parameters were carried out in those mice.
This study provides evidence of the ability of a biohybrid device to induce the growth of differentiated pancreas parenchyma in both normoglycemic and streptozotocin-induced diabetic mice as detected by histological analysis. Glucose metabolism and body weight of hyperglycemic mice bearing hASCs implants improved.
The synthetic porous scaffold bearing hASC cells placed adjacent to the native animal pancreas exhibits the potential to be exploited in future cell-based type 1 diabetes therapies.
为克服1型糖尿病治疗(外源性胰岛素注射)的局限性,已开发出几种使用生物材料承载源自干细胞的胰岛素生成细胞的替代性细胞方法。然而,似乎没有一种方法能满足诱导胰腺细胞在支架上成功定植所需的所有要求。在此,我们报告了一种附着于天然小鼠胰腺的聚合物平台,其填充有人脂肪干细胞(hASC),该平台能够诱导胰腺实质生长。
将合成聚醚 - 聚氨酯圆盘放置在血糖正常和链脲佐菌素诱导的糖尿病小鼠的胰腺附近。植入后第4天,在血糖正常和糖尿病小鼠组的植入物内注射1×10个hASC。对植入物进行免疫组织化学分析,以鉴定新形成组织中的胰岛素阳性细胞。此外,对这些小鼠进行代谢、炎症和血管生成参数检测。
本研究通过组织学分析提供了证据,证明生物杂交装置能够在血糖正常和链脲佐菌素诱导的糖尿病小鼠中诱导分化的胰腺实质生长。植入hASC的高血糖小鼠的葡萄糖代谢和体重得到改善。
放置在天然动物胰腺附近的承载hASC细胞的合成多孔支架在未来基于细胞的1型糖尿病治疗中具有被开发利用的潜力。